Baqsimi ® (glukagon näspulver)

För fullständig produktresumé för Baqsimi® se FASS.

Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska

Baqsimi® (glukagon näspulver): Förvaring

Förvara inte läkemedlet över 30 °C. Förvara endosbehållaren i den krympfilmsförseglade tuben till den ska användas för att skydda den mot fukt.

SE_cFAQ_NG703_DEVICE_STORAGE
SE_cFAQ_NG703_DEVICE_STORAGE
en-GB

Detailed Information

NG is designed to be carried by the person with diabetes throughout the day in both hot and cold conditions.1

It does not require refrigeration, although it can be refrigerated [2° to 8°C] or frozen [not less than -20°C] for up to 24 months (throughout its shelf life).1

It should not be stored above 30°C.2

This medicine should be kept out of the sight and reach of children.3

The user should not remove the shrink wrapping or open the tube until ready to give the dose.2

This is a ready to use medicinal product and for single-use only. 2

The single-dose container consists of polyethylene and polypropylene. The shrink wrapped tube is comprised of polyethylene and polypropylene containing a desiccant.2

If the tube has been opened, the single-dose container may have been exposed to moisture. This could cause the medicinal product to not work as expected. The shrink wrapped tube should be examined periodically. If the tube has been opened, the medicinal product must be replaced.2

The tube is not waterproof.  The  device must be replaced if the product is exposed to water or any other liquid.1

How To Handle Deviations From Recommended Conditions

  • Lilly recommends that the glucagon nasal powder be stored in conditions mentioned above.
  • If glucagon nasal powder is exposed to temperatures outside the recommended storage and handling range, Lilly personnel can perform a product quality assessment to determine potential impact to the product. This product quality assessment is not intended to replace the recommended storage or handling conditions for the product.
    • Please contact Lilly for assistance.

References

1Data on file, Eli Lilly and Company and/or one of its subsidiaries.

2Baqsimi [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

3Baqsimi [package leaflet]. Eli Lilly Nederland B.V., The Netherlands.

Datum fӧr senaste ӧversyn October 02, 2019


Kontakta Medicinsk Information på Lilly

Kontakta oss på telefon

Kontorstid vardagar 9.00-17.00

Eller så kan du

Klicka för att chatta är tillgänglig

Klicka för att chatta är offline

Skriv din fråga till oss